DEADLINE MONDAY: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Nu Skin Enterprises Inc. and a Lead Plaintiff Deadline of March 24, 2014

Loading...
Loading...

NEW YORK, March 21, 2014 /PRNewswire/ -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Utah on behalf of investors who purchased Nu Skin Enterprises Inc. ("Nu Skin" or the "Company") NUS common stock between July 10, 2013 and January 14, 2014.

Click here to learn about the case: http://docs.wongesq.com/NUS-Info-Request-Form-147.  There is no cost or obligation to you.

The complaint alleges that the Company made materially false and/or misleading statements and omitted materially adverse facts regarding the Company's business, operations, and prospects. In particular, it is alleged that the Company engaged in fraudulent sales practices and failed to comply with China's laws and regulations.

If you suffered a loss in Nu Skin you have until March 24, 2014 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.  To obtain additional information, contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit http://docs.wongesq.com/NUS-Info-Request-Form-147.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights.  Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:    
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

Logo - http://photos.prnewswire.com/prnh/20120409/MM84375LOGO

SOURCE The Law Offices of Vincent Wong

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...